159 results
8-K
RGLS
Regulus Therapeutics Inc
17 May 24
Departure of Directors or Certain Officers
4:02pm
the selection by the audit committee of the board of directors of Ernst & Young LLP as the independent registered public accounting firm of the Company
8-K
EX-10.1
615 qx7eu7lgslvw7b0
14 Mar 24
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
4:57pm
8-K
u446swn55ivwzyfhmx
14 Jun 23
Departure of Directors or Certain Officers
4:01pm
DEFA14A
7jgja6xmnqua4187
28 Apr 23
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
j4sq3gmsr8p5m4u5ocg
13 Apr 23
Securities Purchase Agreement
4:05pm